The latest study from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine's Abramson Cancer Center provides compelling evidence that CAR T cell therapy does not induce secondary cancers. This finding comes from an extensive analysis of data involving over 700
Polymetastatic cancer, a condition where cancer has spread to more than 10 spots throughout the body, often leaves patients with limited treatment options. Recent advancements in cancer therapy have focused on high-precision radiation treatments to combat this extensive metastasis. Researchers from
Researchers at the University of Kentucky have pioneered a groundbreaking microscopy technique that may offer an affordable and effective way to study cancer cell metabolism. This innovative method, which focuses on observing metabolic reprogramming within cancer cells, has the potential to
The pharmaceutical and medical technology sectors have long grappled with the complexities of clinical trial management. Traditionally, these processes involved disparate systems and manual workflows, leading to inefficiencies, data silos, and delays. However, the advent of electronic quality
Cervical cancer represents a critical public health issue globally, claiming the life of one woman every two minutes. This statistic highlights the significant mortality associated with a disease that is now considered preventable through vaccination. The burden of cervical cancer is particularly
In a surprising move, Rentschler Biopharma announced its decision to withdraw from the cell and gene therapy (CGT) business at its Stevenage, UK facility, marking a significant shift in the company's strategic focus. This decision comes despite recent investments in building advanced
